We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sanofi | EU:SAN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.22 | -0.24% | 91.68 | 91.66 | 91.69 | 91.94 | 91.60 | 91.83 | 64,840 | 08:38:11 |
From May 2021 to May 2024
By Matt Grossman
Sanofi and Merck & Co.'s pediatric combination vaccine for six diseases is now available in the U.S., the companies said Tuesday.
The vaccine protects against diphtheria, tetanus, pertussis, poliomyelitis, hepatitis B and invasive disease due to Haemophilus influenzae type b. The vaccine, called Vaxelis, has been approved as a three-dose series in children between 6 weeks old and four years old.
Use of the vaccine reduces the number of shots children would get in their first six months of life, said Joanne Monahan, senior vice president of U.S. vaccines at Merck.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
June 01, 2021 07:53 ET (11:53 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
